Inflammatory Mediators in Inflammatory Bowel Disease: Clues for Designer Therapy

Inflammatory Mediators in Inflammatory Bowel Disease: Clues for Designer Therapy

Saved in:

Bibliographic Details
Main Author:	John L Wallace
Format:	Article
Language:	English
Published:	Wiley 1993-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/1993/304839
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel Targets for Anti-Inflammatory Therapy in Inflammatory Bowel Disease
by: John L Wallace
Published: (1994-01-01)

Pathogenesis of Nonsteroidal Anti-Inflammatory Drug Gastropathy: Clues to Preventative Therapy
by: Salim MA Bastaki, et al.
Published: (1999-01-01)

Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997-01-01)

Trends in Inflammatory Bowel Disease Therapy
by: L Sutherland, et al.
Published: (1990-01-01)

Immune-Mediated Cytotoxicity in Inflammatory Bowel Disease
by: Stephan R Targan, et al.
Published: (1990-01-01)

Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein, et al.
Published: (1993-01-01)

Update of Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein
Published: (1994-01-01)

Special Issues in Nutritional Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1993-01-01)

Overview of 5-ASA in Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1994-01-01)

Immunopathogenesis of inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2013-09-01)

Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
by: Ingvar Bjarnason, et al.
Published: (1993-01-01)

Maintenance Therapy for Inflammatory Bowel Disease: What Really Works
by: Lloyd R Sutherland
Published: (1997-01-01)

Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01)

Autoimmunity in Inflammatory Bowel Disease
by: Kiron M Das
Published: (1993-01-01)

Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997-01-01)

Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01)

Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update
by: Shane O’Sullivan, et al.
Published: (2015-01-01)

Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease
by: Qiyue Wang, et al.
Published: (2020-01-01)

Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target
by: Anna Socha-Banasiak, et al.
Published: (2021-01-01)

Trends in Inflammatory Bowel Disease Therapy: A Meta-Analytic Approach
by: Gregory W Whiting, et al.
Published: (1995-01-01)

Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Treatment of Inflammatory Bowel Disease in Children
by: D Grant Gall
Published: (1990-01-01)

Osteomyelitis and Osteonecrosis in Inflammatory Bowel Disease
by: Hugh J Freeman
Published: (1997-01-01)

The Changing Phenotype of Inflammatory Bowel Disease
by: Carthage Moran, et al.
Published: (2016-01-01)

Thromboelastography in Patients with Inflammatory Bowel Disease
by: Yonghua Shen, et al.
Published: (2020-01-01)

Ocular Complications of Inflammatory Bowel Disease
by: Rana Mady, et al.
Published: (2015-01-01)

Cancer Risk in Inflammatory Bowel Disease
by: Anders M Ekbom
Published: (1995-01-01)

Review of Inflammatory Bowel Disease in China
by: Lingna Ye, et al.
Published: (2013-01-01)

T Cell Repertoire and Inflammatory Bowel Disease
by: Kenneth Croitoru, et al.
Published: (1996-01-01)

The Influence of Nutrients on Inflammatory Bowel Diseases
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2020-01-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

Noninvasive markers of inflammatory bowel disease activity
by: A. V. Nikitin, et al.
Published: (2018-08-01)

Antioxidant and anti-inflammatory roles of tea polyphenols in inflammatory bowel diseases
by: Van-Long Truong, et al.
Published: (2022-05-01)

Leukocyte migration in experimental inflammatory bowel disease
by: E. P. Van Rees, et al.
Published: (1997-01-01)

Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment?
by: Christian Philipp Selinger, et al.
Published: (2024-06-01)

Therapy of Inflammatory Bowel Disease using New 5-ASA Compounds: An Introduction
by: Ulrich Klotz
Published: (1989-01-01)

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease
by: C. J. J. Mulder, et al.
Published: (1998-01-01)